Cited by 106Alzheimer's disease research and treatmentsAtherosclerosis and Cardiovascular DiseasesNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

The p38 MAP kinase signaling pathway in Alzheimer's disease

Johnson, G·2003·Experimental Neurology

DOI 10.1016/s0014-4886(03)00268-1

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0014-4886(03)00268-1

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,440
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB
Deák, M., Clifton, A. D., Lucocq, J. M., & Alessi, D. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4426 · Cited by 1,004
Stress-Induced Phosphorylation and Activation of the Transcription Factor CHOP (GADD153) by p38 MAP Kinase
Wang, X., & Ron, D. (1996) · Science · doi:10.1126/science.272.5266.1347 · Cited by 885
Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)
Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J. A., Lin, S., & Han, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17920 · Cited by 746
FGF and stress regulate CREB and ATF‐1 via a pathway involving p38 MAP kinase and MAPKAP kinase‐2.
Tan, Y., Rouse, J. W., Zhang, A., Cariati, S., Cohen, P., & Comb, M. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00840.x · Cited by 634
Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl Imidazoles
Kumar, S., McDonnell, P., Gum, R. J., Hand, A. T., Lee, J. C., & Young, P. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6849 · Cited by 507

Show all 60 references

Sorted by citations

Activation and signaling of the p38 MAP kinase pathway
Zarubin, T., & Han, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290257 · Cited by 1,711
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
Rajmohan, R., & Reddy, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160612 · Cited by 724
p38MAPK: stress responses from molecular mechanisms to therapeutics
Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 683
Synthesis and biological activity of pyrrole, pyrroline and pyrrolidine derivatives with two aryl groups on adjacent positions
Bellina, F., & Rossi, R. (2006) · Tetrahedron · doi:10.1016/j.tet.2006.05.024 · Cited by 607
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 381
Amyloid Beta in Aging and Alzheimer’s Disease
Sehar, U., Rawat, P., Reddy, A. P., Kopel, J. J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112924 · Cited by 399
Amyloid-β Aggregation
Finder, V. H., & Glockshuber, R. (2007) · Neurodegenerative Diseases · doi:10.1159/000100355 · Cited by 367
RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease
Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335
Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation
Babu, J. R., Geetha, T., & Wooten, M. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03181.x · Cited by 315
p38 MAP Kinase's Emerging Role as a Tumor Suppressor
Bulavin, D. V., & Fornace, A. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92005-2 · Cited by 303
Recent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274
Intrathecal minocycline attenuates peripheral inflammation‐induced hyperalgesia by inhibiting p38 MAPK in spinal microglia
Hua, X., Svensson, C. I., Matsui, T., Fitzsimmons, B., Yaksh, T. L., & Webb, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04451.x · Cited by 248
A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model
Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224
AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
Mizuno, S., Iijima, R., Ogishima, S., Kikuchi, M., Matsuoka, Y., Ghosh, S., Miyamoto, T., Miyashita, A., Kuwano, R., & Tanaka, H. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-52 · Cited by 158
Phospholipase A2 and arachidonic acid in Alzheimer's disease
Sanchez-Mejia, R. O., & Mucke, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.013 · Cited by 148
Glia Proinflammatory Cytokine Upregulation as a Therapeutic Target for Neurodegenerative Diseases: Function‐Based and Target‐Based Discovery Approaches
Eldik, L. J. V., Thompson, W. L., Ranaivo, H. R., Behanna, H. A., & Watterson, D. M. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82015-0 · Cited by 141
Effects of p38 MAPK Inhibition on Early Stages of Diabetic Retinopathy and Sensory Nerve Function
Du, Y., Tang, J., Li, G., Berti-Mattera, L., Lee, C. A., Bartkowski, D., Gale, D., Monahan, J., Niesman, M. R., Alton, G., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3674 · Cited by 136
Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection
Boergeling, Y., Schmolke, M., Viemann, D., Nordhoff, C., Roth, J., & Ludwig, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.469239 · Cited by 135
An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease
Cavallini, A., Brewerton, S., Bell, A., Sargent, S., Glover, S., Hardy, C., Moore, R., Calley, J., Ramachandran, D., Poidinger, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463984 · Cited by 133
“Moreover, neuroinflammation is increasingly linked to pathogenesis of Alzheimer disease (29, 30); thus; inhibition of the p38 pathway may slow AD progression through anti-inflammatory mechanisms.”
Background
The Role of Specific Mitogen-Activated Protein Kinase Signaling Cascades in the Regulation of Steroidogenesis
Manna, P. R., & Stocco, D. M. (2011) · Journal of Signal Transduction · doi:10.1155/2011/821615 · Cited by 127
Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK
Maezawa, I., Nivison, M. P., Montine, K. S., Maeda, N., & Montine, T. J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5423fje · Cited by 117
A Review on Solvent-free Methods in Organic Synthesis
Zangade, S., & Patil, P. (2020) · Current Organic Chemistry · doi:10.2174/1385272823666191016165532 · Cited by 107
RAGE mediates Aβ accumulation in a mouse model of Alzheimer’s disease via modulation of β- and γ-secretase activity
Fang, F., Yu, Q., Arancio, O., Chen, D., Gore, S. S., Yan, S. S., & Yan, S. F. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy017 · Cited by 103
Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Albuquerque, H. M. T., Santos, C. M. M., Cavaleiro, J. A. S., & Silva, A. M. S. (2014) · Current Organic Chemistry · doi:10.2174/1385272819666141013224253 · Cited by 100
ERK1/2 is an endogenous negative regulator of the γsecretase activity
Kim, S., Park, H., Hong, H. S., Baik, E. J., Jung, M. W., & Mook‐Jung, I. (2006) · The FASEB Journal · doi:10.1096/fj.05-4055fje · Cited by 92
Aberrant phosphorylation in the pathogenesis of Alzheimer's disease
Chung, S. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.8.467 · Cited by 92
IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1+/- mice display increases atherosclerotic plaque stability
Fang, S., Sun, S. Y., Cai, H., Zou, X., Wang, S., Hao, X., Wan, X. H., Tian, J., Li, Z., He, Z., et al. (2021) · Theranostics · doi:10.7150/thno.62797 · Cited by 85
Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine
COLOGNATO, R., LAURENZA, I., FONTANA, I., COPPEDE, F., SICILIANO, G., COECKE, S., ARUOMA, O., BENZI, L., & MIGLIORE, L. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2005.10.005 · Cited by 81
Activation of PAR-1 Kinase and Stimulation of Tau Phosphorylation by Diverse Signals Require the Tumor Suppressor Protein LKB1
Wang, J.-W., Imai, Y., & Lu, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5094-06.2007 · Cited by 80
“Significantly, recent findings have provided strong evidence that the p38 MAPK signaling cascade is overactivated in AD (Zhu et al., 2001; Johnson and Bailey, 2003; Sun et al., 2003).”
Background
Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference
Zhang, X., Cui, Y., Cui, Y., Chen, Y., Na, X.-D., Chen, F., Wei, X., Li, Y.-Y., Liu, X., & Xin, W. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.017 · Cited by 80
Activation of p38 MAPK Is Required in Monocytic and Neuronal Cells for HIV Glycoprotein 120-Induced Neurotoxicity
Medders, K. E., Sejbuk, N. E., Maung, R., Desai, M. K., & Kaul, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902535 · Cited by 80
Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades
Yang, Z., Song, L., & Huang, C. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909790192383 · Cited by 79
RAGE is a key cellular target for A -induced perturbation in Alzheimer s disease
Yan, S. S. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/265 · Cited by 108
Curcumenol isolated from Curcuma zedoaria suppresses Akt-mediated NF-κB activation and p38 MAPK signaling pathway in LPS-stimulated BV-2 microglial cells
Lo, J. Y., Kamarudin, M. N. A., Hamdi, O. A. A., Awang, K., & Kadir, H. A. (2015) · Food & Function · doi:10.1039/c5fo00607d · Cited by 71
Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells
Ahad, A., Ahsan, H., Mujeeb, M., & Siddiqui, W. A. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.08.026 · Cited by 69
Molecular effects of fermented papaya preparation on oxidative damage, MAP Kinase activation and modulation of the benzo[a]pyrene mediated genotoxicity
Aruoma, O. I., Colognato, R., Fontana, I., Gartlon, J., Migliore, L., Koike, K., Coecke, S., Lamy, E., Mersch‐Sundermann, V., Laurenza, I., et al. (2006) · BioFactors · doi:10.1002/biof.5520260205 · Cited by 69
N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein
Ando, K., Uemura, K., Kuzuya, A., Maesako, M., Asada-Utsugi, M., Kubota, M., Aoyagi, N., Yoshioka, K., Okawa, K., Inoue, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158477 · Cited by 66
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Kim, Y., Lim, J., & Oh, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117277 · Cited by 66
Phytosterols in Seaweeds: An Overview on Biosynthesis to Biomedical Applications
Sohn, S.-I., Rathinapriya, P., Balaji, S., Balan, D. J., Swetha, T. K., Durgadevi, R., Alagulakshmi, S., Singaraj, P., & Pandian, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312691 · Cited by 64
Mitogen-activated protein kinases and the evolution of Alzheimer’s: a revolutionary neurogenetic axis for therapeutic intervention?
Haddad, J. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.06.002 · Cited by 61
Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain
Sun, S., Chen, D., Lin, F., Chen, M., Yu, H., Hou, L., & Li, C. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.08.006 · Cited by 60
Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease
DeVaughn, S., Müller‐Oehring, E. M., Markey, B. M., Bronte-Stewart, H. M., & Schulte, T. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9305-x · Cited by 56
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy
Tosi, G., Pederzoli, F., Belletti, D., Vandelli, M. A., Forni, F., Duskey, J. T., & Ruozi, B. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.001 · Cited by 53
Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation
Sui, Z., Fan, S., Sniderhan, L. F., Reisinger, E., Stout, A., Schifitto, G., Gelbard, H. A., Dewhurst, S., & Maggirwar, S. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.702 · Cited by 52
Roles of p38 MAPK signalling in intervertebral disc degeneration
Shi, Z., Zhu, L., Song, Z., Liu, T.-J., & Hao, D. (2023) · Cell Proliferation · doi:10.1111/cpr.13438 · Cited by 50
The many faces of p38 mitogen-activated protein kinase in progenitor/stem cell differentiation
Oeztuerk-Winder, F., & Ventura, J. (2012) · Biochemical Journal · doi:10.1042/bj20120401 · Cited by 48
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases
Amiri, A., Barreto, G. E., Sathyapalan, T., & Sahebkar, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210402104054 · Cited by 46
Age-induced augmentation of p38 MAPK phosphorylation in mouse lung
Li, Z., Li, J., Bu, X., Liu, X., Tankersley, C. G., Wang, C., & Huang, K. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.04.005 · Cited by 45
Synergistic Inhibition of ERK1/2 and JNK, Not p38, Phosphorylation Ameliorates Neuronal Damages After Traumatic Brain Injury
Bhowmick, S., D’Mello, V., & Muneer, P. M. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1132-7 · Cited by 44
Neurotoxic prostaglandin J2 enhances cyclooxygenase‐2 expression in neuronal cells through the p38MAPK pathway: A death wish?
Li, Z., Jansen, M., Ogburn, K. D., Salvatierra, L., Hunter, L., Mathew, S., & Figueiredo‐Pereira, M. E. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20346 · Cited by 39
Integrating multi-source information on a single network to detect disease-related clusters of molecular mechanisms
Zachariou, M., Minadakis, G., Oulas, A., Afxenti, S., & Spyrou, G. M. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.03.009 · Cited by 38
Role of protein kinases in neurodegenerative disease: cyclin-dependent kinases in Alzheimer's disease
Edward, A. M. I. (2005) · Frontiers in bioscience · doi:10.2741/1516 · Cited by 39
Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus
Nie, K., Yu, J., Fu, Y., Cheng, H., Chen, F.-Y., You, Q., & Han, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.010 · Cited by 36
Mini review–vanadium-induced neurotoxicity and possible targets
Jaiswal, M. R., & Kale, P. P. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04188-5 · Cited by 36
d-ribose and pathogenesis of Alzheimer’s disease
Javed, M., Ahmad, M. I., Javed, H., & Naseem, S. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05243-7 · Cited by 27
Transcription Factor Sp1 in the Expression of Genes Encoding Components of Mapk, JAK/STAT, and PI3K/Akt Signaling Pathways
Ivanenko, K. A., Prassolov, V., & Khabusheva, E. (2022) · Molecular Biology · doi:10.1134/s0026893322050089 · Cited by 27
Prevention of Trabecular Bone Loss Induced by Estrogen Deficiency by a Selective p38α Inhibitor
Caverzasio, J., Higgins, L., & Ammann, P. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080410 · Cited by 29
Structure- and ligand-based drug design of novel p38-alpha MAPK inhibitors in the fight against the Alzheimer’s disease
Pinsetta, F. R., Taft, C. A., & da Silva, C. H. T. D. P. (2013) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2013.803441 · Cited by 25
Diabetes and Alzheimer's Disease - Is There a Connection?
Sima, A. A. F., & Li, Z.-G. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.161 · Cited by 25
Advanced stent coating for drug delivery and in vivo biocompatibility
Liu, Y., Wang, W., Acharya, G., Shim, Y., Choe, E. S., & Lee, C. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1962-1 · Cited by 23
Myeloid-restricted CD68 deficiency attenuates atherosclerosis via inhibition of ROS-MAPK-apoptosis axis
Duan, L., Zhao, Y., Jia, J., Chao, T., Wang, H., Liang, Y., Lou, Y., Zheng, Q., & Wang, H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166698 · Cited by 20
Genes Related with Alzheimer’s Disease: A Comparison of Evolutionary Search, Statistical and Integer Programming Approaches
Moscato, P., Berretta, R. E., Hourani, M., Mendes, A. S., & Cotta, C. (2005) · Lecture notes in computer science · doi:10.1007/978-3-540-32003-6_9 · Cited by 20
Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity
Li, X., Gu, Y., Ma, L., Bai, X., Jie, J., Zhang, X.-F., & Chen, D. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238621 · Cited by 19
Increase in Alzheimer's related markers preceeds memory disturbances: Studies in vasopressin-deficient Brattleboro rat
Varga, J. M., Klausz, B., Domokos, Á., Kálmán, S., Pákáski, M., Szücs, S., Garab, D., Zvara, Á., Puskás, L. G., Kalman, J. L., et al. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.10.010 · Cited by 19
Recent advances in experimental modeling of the assembly of tau filaments
Ko, L., Deture, M. A., Sahara, N., Chihab, R., Vega, I. E., & Yen, S.-H. C. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.004 · Cited by 19
Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders
Gendelman, H. E., & Gelbard, H. A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000111 · Cited by 18
Deletion of Apoptosis Signal–Regulating Kinase–1 Prevents Ventilator-Induced Lung Injury in Mice
Makena, P. S., Gorantla, V. K., Ghosh, M. C., Bezavada, L., Kandasamy, K., Balázs, L., Luellen, C. L., Thompson, K. E., Parthasarathi, K., Ichijo, H., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0234oc · Cited by 18
Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Almasoudi, S. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Eliwa, D., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111296 · Cited by 16
Hyperuricemia induces lipid disturbances by upregulating the CXCL-13 pathway
Meng, J., Lv, Q., Sui, A., Xu, D., Zou, T., Song, M., Gong, X., Xing, S., & Wang, X. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00285.2021 · Cited by 14
p38 Mitogen-activated protein kinase mediates hypoxia-induced vascular endothelial growth factor release in human endothelial cells.
Fan, B., Wang, Y., Yao, T., & Zhu, Y.-C. (2005) · PubMed · Cited by 14
Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
Kopel, J. J., Sehar, U., Choudhury, M., & Reddy, P. H. (2023) · Healthcare · doi:10.3390/healthcare11060868 · Cited by 15
Unravelling Immunity: Understanding Inflammatory Pathways as Key Players in Immune Response and Disease Progression
Ghara, A., Matada, G. S. P., Sah, R. K., Sneha, S., Boneka, S. S., Paik, A., Majumder, S., Pramanick, P., & Metikurki, B. (2025) · Current Molecular Biology Reports · doi:10.1007/s40610-025-00167-2 · Cited by 12
Targeting the non‐ATP‐binding pocket of the MAP kinase p38γ mediates a novel mechanism of cytotoxicity in cutaneous T‐cell lymphoma (CTCL)
Zhang, X. H., Chen, C., Li, H., Hsiang, J., Wu, X., Hu, W., Horne, D. A., Nam, S., Shively, J. E., & Rosen, S. T. (2021) · FEBS Letters · doi:10.1002/1873-3468.14186 · Cited by 11
Multi-omics analysis revealed the role of CCT2 in the induction of autophagy in Alzheimer’s disease
Ma, X., Feng, Y., Quan, X., Geng, B., Li, G., Fu, X., & Zeng, L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.967730 · Cited by 11
Nonfibrillar Abeta1–42 Inhibits Glutamate Uptake and Phosphorylates p38 in Human Fibroblasts
Zoia, C., Riva, C., Isella, V., Proserpio, P., Terruzzi, A., Arban, S., Salerno, D., Cassina, V., Mantegazza, F., Tremolizzo, L., et al. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181f9860f · Cited by 11
Studies on the Expression of Fibroblast Growth Factor-2 from Odontoblast-like Cells
Oliveira, S. H. P., & Santos, V. A. C. (2011) · Journal of Endodontics · doi:10.1016/j.joen.2011.08.004 · Cited by 10
Could Direct Inhibition of Inflammation Be the “Next Big Thing” in Treating Atherosclerosis?
Natarajan, P., & Cannon, C. P. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213793 · Cited by 10
Effect of Phosphorylated-Extracellular Regulated Kinase 1/2 Inhibitor on Retina from Light-induced Photoreceptor Degeneration
Ding, X.-Y., Gu, R.-P., Tang, W.-Y., Shu, Q.-M., Xu, G.-Z., & Zhang, M. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.246064 · Cited by 10
Anorexigenic neuropeptides as anti-obesity and neuroprotective agents
Strnadová, V., Pačesová, A., Charvát, V., Šmotková, Z., Železná, B., Kuneš, J., & Maletı́nská, L. (2024) · Bioscience Reports · doi:10.1042/bsr20231385 · Cited by 8
In vitro and in vivo assessment of diosmetin-loaded lactoferrin-modified liposomes for brain delivery in intracerebral hemorrhage therapy
Gu, Y., Luo, H., Zhu, J., Ma, H., Zhang, Y., Xing, J., Liu, Y., Cai, Y., Sun, W., & Luo, P. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01826-8 · Cited by 8
Tetrabromobisphenol A induced p38-MAPK/AMPKα activation downstream-triggered CHOP signal contributing to neuronal apoptosis and death
Liu, J., Liu, S., Fu, S.-C., Lai, W.-C., Fang, K., Lin, K.-A., Ke, J.-A., Kuo, C.-Y., Su, C., & Chen, Y. (2024) · Toxicology · doi:10.1016/j.tox.2024.154014 · Cited by 7
The relationship mammalian p38 with human health and its homolog Hog1 in response to environmental stresses in Saccharomyces cerevisiae
Du, G., Zheng, K., Sun, C., Sun, M., Pan, J., Meng, D., Guan, W., & Zhao, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1522294 · Cited by 7
Pathobiology of Diabetic Encephalopathy in Animal Models
Sima, A. A. F. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_17 · Cited by 6
Baicalin alleviates intervertebral disc degeneration by inhibiting the p38 MAPK signaling pathway
Wu, Y., Li, F., Shu, S., Feng, Z., Qiu, Y., Li, S., & Zhu, Z. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112743 · Cited by 5
Brain chemotherapy from the bench to the clinic: targeting neuronal survival with small molecule inhibitors of apoptosis
Paul, C. C. (2005) · Frontiers in bioscience · doi:10.2741/1551 · Cited by 5
DUSP1/MKP-1 represents another piece in the P2X7R intracellular signaling puzzle in cerebellar cells: our last journey with Mª Teresa along the purinergic pathways of Eden
Gil‐Redondo, J. C., Queipo, M. J., Trueba, Y., Llorente-Sáez, C., Serrano-López, J., Ortega, F., Gómez‐Villafuertes, R., Pérez‐Sen, R., & Delicado, E. G. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09970-x · Cited by 4
Molecular Aspects of Memory Dysfunction in Alzheimer’s Disease
Chin, J., Roberson, E. D., & Mucke, L. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00015-2 · Cited by 4
Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase.
Moallem, S. A., Hadizadeh, F., Abadi, F. A., Shahraki, M., & Shamsara, J. (2012) · Europe PMC (PubMed Central) · Cited by 3
Improved immunohistochemical detection of phosphorylated mitogen-activated protein kinases in the injured rat optic nerve head
Mammone, T., Chidlow, G., Casson, R. J., & Wood, J. P. M. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01771-x · Cited by 3
Immediate Early Genes, Inducible Transcription Factors and Stress Kinases in Alzheimer’s Disease
Ferrer, I., Santpere, G., & Puig, B. (2006) · Springer eBooks · doi:10.1007/978-0-387-33604-6_13 · Cited by 2
S-deoxydihydroglyparvin from Glycosmis parva inhibits lipopolysaccharide induced murine macrophage activation through inactivating p38 mitogen activated protein kinase
Laprasert, C., Chansriniyom, C., & Limpanasithikul, W. (2021) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_64_20 · Cited by 2
Chemical degradation identified Human p38-MAPK as a host target to combat parasitic infectionsPreprint
Singhal, J., Rawat, N., Bansal, R., Srivastava, P., Ghousepeer, G. D., Pandey, R. P., Ranganathan, A., & Singh, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.19.629355 · Cited by 2
Design strategies, structural insights, and biological potential of amyloid-beta inhibitors in Alzheimer’s disease
Guleria, M., Malhan, A., Teli, G., Bisht, N., & Jain, S. K. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11278-4 · Cited by 1
Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease ☆
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Quinase p38 alfa como alvo para o planejamento de fármacos em Mal de Alzheimer
Pinsetta, F. R. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2013.tde-06092013-104102 · Cited by 1
Proteomic analysis of inflammatory protein expression patterns in cell culture and transgenic animal models for Alzheimer's disease
Augé, C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003617456
Sinalização intracelular desencadeada por concentrações subtóxicas de estreptozotocina em células neuro-2A: modelo in vitro de neurodegeneração associada à doença de Alzheimer.
Mazucanti, C. H. (2013) · doi:10.11606/d.42.2013.tde-26092013-102423
Anti‐Inflammatory/Analgesics: An In‐Depth Look at p 38 MAP Kinases
Brown, K. L. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse446
Inhibitory effects of compounds isolated from ethyl acetate extracts of Glycosmis parva branches and leaves on LPS-induced RAW 264.7 macrophage activation
Laprasert, C. (2019) · doi:10.58837/chula.the.2019.421

Authors: Johnson, G.
Affiliations: University of Alabama at Birmingham (US)
Corresponding author: Johnson, G
ORCID: Johnson, G
Venue: Experimental Neurology
Publisher: Elsevier BV
Published: 2003-10
Volume: 183
Issue: 2
Pages: 263-268
ISSN: 0014-4886 (ISSN-L)
DOI: 10.1016/s0014-4886(03)00268-1
OpenAlex: W1994973104
Cited by: 106
References: 60
Citations by year: 2026: 1 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 2 · 2019: 4 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 8 · 2012: 5
FWCI: 3.96
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Experimental Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: p38 MAPK, Alzheimer's disease, CD68, scavenger receptors, atherosclerosis, macrophages, oxidized LDL, macrophage apoptosis, reactive oxygen species, MAPK signaling, necrotic core, ApoE-deficient mice, coronary artery disease
MeSH terms: Alzheimer Disease, Animals, Humans, Substrate Specificity, Signal Transduction, tau Proteins, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The p38 MAP kinase signaling pathway in Alzheimer's disease

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks